Lucid Air Grand Touring secures the top spot in a grueling Nordic winter range test, providing a much-needed technical validation for the luxury EV maker amidst a challenging market climate.
Life sciences and diagnostics firm Revvity (RVTY) closed 2025 with results surpassing internal targets, driven by robust diagnostics performance. While management provided initial 2026 guidance, it remains conservative, banking on market stabilization rather than a broad recovery.
As Kevin Warsh emerges as a frontrunner for Federal Reserve Chair, former colleagues paint a picture of a consensus-seeking listener. But with the Fed facing internal divisions and external pressure, questions remain: Is his collaborative style the steady hand needed, or a potential liability in times of crisis?
The Norwegian monarchy is rocked by dual crises as Marius Borg Høiby, son of Crown Princess Mette-Marit, stands trial on serious criminal charges, while newly unsealed Jeffrey Epstein documents reveal extensive past connections to the princess.
Twist Bioscience kicks off fiscal 2026 with robust growth, reporting a 17% year-over-year revenue increase to $103.7 million. The company credits its semiconductor-based DNA synthesis platform and surging demand from AI-enabled drug discovery programs as key drivers, while reiterating its path to adjusted EBITDA breakeven within the year.
After a prolonged correction, Brent crude oil is showing signs of a potential trend reversal, with a forming double bottom pattern pointing toward a technical target near $95 per barrel. The shift comes amid a tightening physical market and simmering geopolitical risks.
Amidst sluggish sales and intense competition, Target appoints Michael Fiddelke as CEO and refreshes its board, placing store revitalization and operational efficiency at the heart of its turnaround strategy.
Revvity (NYSE: RVTY) surged past fourth-quarter expectations and issued an upbeat 2026 outlook, driven by robust demand in its diagnostics division. The medical equipment maker's performance highlights a sector-wide resilience despite ongoing softness in academic research funding.
Varonis Systems (VRNS) is set to report Q4 earnings after the bell Tuesday, with investors watching closely for signs of resilience after recent revenue misses and a broader sell-off in cybersecurity stocks.
Harmony Biosciences CFO Sandip Kapadia has liquidated his entire direct stake in the company, a move that contrasts sharply with the firm's robust financial performance and bullish $1 billion revenue target for its flagship drug WAKIX by 2026. While the sales were pre-planned, the timing fuels debate on insider confidence versus corporate optimism.
Elon Musk stated that SpaceX's measures to prevent Russia's unauthorized use of Starlink appear effective. Meanwhile, Ukrainian officials are developing a system to restrict terminal access on its territory, highlighting the ongoing tech dimension of the conflict.
Archer-Daniels-Midland (ADM) is set to report Q4 earnings Tuesday morning. Analysts project a slight revenue dip, but investor sentiment remains cautiously optimistic as the agribusiness leader navigates a volatile global market.
President Trump's nomination of former Fed Governor Kevin Warsh to lead the central bank sets the stage for a pivotal confirmation battle, raising questions about monetary policy direction and the erosion of the Fed's political firewall.
Defense contractor L3Harris Technologies has been awarded a U.S. Navy contract to advance the Marine Corps' precision-strike capabilities with its long-range Red Wolf missile system, designed to counter maritime threats in the Pacific.
Netflix shares face pressure as the streaming giant's 2026 revenue guidance signals a significant growth deceleration, even with its advertising business poised to double. Investor concerns are compounded by a potential multi-billion dollar acquisition.
From innovative financing for indie labels to major acquisitions in live events, the music business landscape is being reshaped by a series of strategic partnerships and investments unveiled over the past fortnight.
President Donald Trump's selection of former Fed Governor Kevin Warsh to lead the central bank is widely seen as a move to accelerate the rollback of post-crisis financial rules and align regulatory policy more closely with White House objectives, analysts say.
American Express reported a 10% revenue surge to $72 billion for 2025, driven by strong premium card demand and disciplined credit. Executives project 9-10% growth for 2026, betting on younger customers and strategic tech investments to sustain momentum.
The trading platform's launch of commission-free event contracts for the Big Game has sparked interest, but its shares continue to struggle, raising questions about its valuation and growth narrative.
President Donald Trump has nominated Kevin Warsh, a former Federal Reserve governor and critic of current monetary policy, to succeed Jerome Powell as Chair of the Federal Reserve, setting the stage for a potential shift in the central bank's direction.
